image
Xilio Therapeutics, Inc. XLO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.815
8.44 %
$ 42.2 M
Market Cap
-0.75
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
79.85%
EBIT Estimate
27.68%
Net Income Estimate
0.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Xilio Therapeutics, Inc.
image
XLO has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart XLO

image
$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart XLO

image
$40.0m$40.0m$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart XLO

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)($90.0m)($90.0m)20232023202420242025202520262026202720272028202820292029